MyOme
PrivateLast Round
VC Round
Dec 11, 2025
Est. Valuation
$132M
Total Funding Raised
$36.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MyOme is a biotechnology company that offers gene analytics technology to assess the impact of DNA on health and well-being through genome sequencing, helping families understand and mitigate the risk of hereditary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyOme Comparables
Compare MyOme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Variantyx | 79% | |
| Nucleus Genomics | 79% | |
| Genomic Prediction | 70% | |
MyOme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 11, 2025 | ||||
| Series B | Jun 21, 2022 | ||||
| Series A | Oct 23, 2019 | ||||
| Seed | Jul 17, 2019 |
MyOme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders Fund | Series B |
| SoftBank Group | Series B |
| Norwest Venture Partners | Series A, Series B, Seed |
| Sequoia Capital | Series B, VC Round |
| Foresite Capital | Series B |
| SoftBank Corp | Series B |
| HOF Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Dr. Ravi Thadhani joins the Board of Directors.
- Apr 21, 2026
Sam Roosz appointed to the Board of Directors.
MyOme Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MyOme's valuation, stock price, and market status.